Because of COVID-19, many FMCG companies such as Dabur, Marico, Emami, ITC, and even new age brands are gradually focusing on selling Ayurveda-based and immunity-boosting products. These brands are incessantly growing their portfolio of immunity-boosting products in line with the accelerated consumer shift to healthy food and beverage options. Amid the pandemic, consumers are now demanding immunity boosters, and this trend is boosting FMCG immunity portfolio unit sales by 13.5 percent in 2020, up from 3.9 percent in 2019, confirmed market researcher Kantar. According to Mohit Malhotra, Chief Executive Officer, Dabur India Ltd people have become more inclined to prophylactic health remedies, especially immunity boosting products. In view of this changing consumer behaviour, Dabur revamped its portfolio mix, with immunity-boosting healthcare gaining prominence. They have not only increased our R&D spending, but they have also ensured that innovations are targeted and brought to market quickly.